Nav: Home

Popular Hepatitis News and Current Events

Popular Hepatitis News and Current Events, Hepatitis News Articles.
Sort By: Most Relevant | Most Recent
Page 1 of 25 | 1000 Results
Morris Animal Foundation study identifies new virus in cat
Morris Animal Foundation-funded researchers from the University of Sydney have found a previously undiscovered hepadnavirus in an immunocompromised cat, and subsequently in banked samples. (2018-05-17)
Icelandic program seeks to eliminate HCV
A new Journal of Internal Medicine study describes an innovative program to eliminate hepatitis C virus (HCV) as a public health threat in Iceland. (2018-03-07)
How to select anti-hepatitis B virus agents for drug-resistance patients?
Chronic hepatitis B virus (HBV) infection remains a global public health problem. (2008-09-24)
Hepatitis C virus screening rates remain low among baby boomers
Despite the steady increase of liver cancer incidence in the United States in recent decades, data from 2015 indicates that less than 13 percent of individuals born between 1945 and 1965 are estimated to have undergone screening for hepatitis C virus (HCV). (2018-03-27)
Nano vaccine for hepatitis B shows promise for third world
A new needle-less vaccine is highly effective and can be stored without refrigeration, University of Michigan studies in animals show. (2008-08-12)
Vitamin D deficiency common in patients with IBD, chronic liver disease
The 73rd Annual Scientific Meeting of the American College of Gastroenterology in Orlando found patients with inflammatory bowel disease or chronic liver disease were at increased risk of developing Vitamin D deficiencies. (2008-10-06)
Screening for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis achieving sustained virological response is likely to be cost effective
A Canadian study suggests that biannual or annual ultrasound screening for HCC is likely to be cost effective after a sustained virological response in those with hepatitis C-related cirrhosis, but not in those with advanced fibrosis without cirrhosis. (2018-04-12)
Hepatitis C: A novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus is the diagnosis of chronic cases that are generally asymptomatic. (2018-04-10)
The risk factors of idiopathic pulmonary fibrosis in HCV patients
A group from Toranomon Hospital of Japan investigated the cumulative development incidence and predictive factors for idiopathic pulmonary fibrosis in HCV positive patients. (2008-10-23)
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world. (2017-09-15)
Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other races. (2008-05-19)
HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs
HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs. (2018-04-13)
Hepatitis C virus elimination programmes report encouraging results: Is elimination within reach?
ILC 2018: National programmes in Georgia and Iceland report high levels of engagement, treatment initiation, and cure, suggesting HCV elimination targets are achievable. (2018-04-13)
New MRI tech could help doctors detect heart disease with better accuracy
Doctors might be able to better detect any disease or disorder that involves inflammation thanks to a new MRI imaging technology co-developed by faculty at Binghamton University, State University of New York. (2017-12-13)
Linkage to care specialist facilitates access to hepatitis C treatment for people who inject drugs
A longitudinal study involving more than 1,000 individuals reports promising role for linkage to care specialists in expanding access to hepatitis C treatment for people who inject drugs. (2018-04-12)
HEPAHEALTH Project Report -- risk factors and the burden of liver disease in Europe and selected Central Asian countries
The HEPAHEALTH Project Report, which was presented today in a press conference at The International Liver Congress trade; 2018 in Paris, France, is the second overview commissioned by EASL on the burden of liver disease in Europe. (2018-04-12)
Sustained virological response to oral hepatitis C virus treatment associated with reduced mortality in an Italian cohort
A large-scale, real-world data on the course of liver disease after clearance of HCV with direct-acting antiviral agents show reduced risk of death at all stages of disease. (2018-04-13)
Hepatitis C virus may need enzyme's help to cause liver disease
A key enzyme may explain how hepatitis C infection leads to serious liver diseases, reports the University of Pittsburgh Graduate School of Public Health. (2008-07-09)
Discovery of new Hepatitis C virus mechanism
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions. (2016-07-27)
A new protocol for Hepatitis A vaccination to prevent a vaccine-resistant virus
Researchers of the University of Barcelona (UB) have analysed, with massive sequencing techniques for the first time, the evolution of the Hepatitis A virus with samples from patients. (2019-02-08)
Hepatitis therapy: Kupffer cells adjust the balance between pathogen control and hepatocyte regenera
Scientists from TWINCORE have now published new insights on the processes involved in liver inflammation in the Journal of Hepatology: Type I interferons, on the one hand, limit viral replication and thereby help the immune cells to control the viral pathogen. (2018-01-17)
New affordable hepatitis C combination treatment shows 97 percent cure rate
The sofosbuvir/ravidasvir combination treatment for hepatitis C has been shown to be safe and effective, with extremely high cure rates, according to interim results from the Phase II/III STORM-C-1 trial presented by DNDi at the International Liver Conference in Paris. (2018-04-12)
Global burden of disease study focuses on liver cancer
A new article published by JAMA Oncology reports the results of the Global Burden of Disease 2015 study on primary liver cancer incidence, death and years of healthy life lost in 195 countries or territories from 1990 to 2015. (2017-10-05)
Counterattack of the hepatitis B virus
The hepatitis B virus (HBV) infects liver cells. Drugs are available to treat HBV, but they rarely cure the infection, and so the virus typically returns after the treatment ends. (2016-03-16)
Insurance denials for new hepatitis C drugs remain high nationwide, study suggests
Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the US in 2014. (2018-06-07)
How viruses disarm the immune system
How do viruses that cause chronic infections, such as HIV or hepatitis c virus, manage to outsmart their hosts' immune systems? (2018-02-05)
Study finds racial differences in cure rates for Hepatitis C
In a large ethnically diverse group of patients seen at a community-based Veterans Affairs practice, cure rates for chronic hepatitis C were lower for African American individuals relative to White individuals, even when patients were receiving optimal therapies. (2018-02-22)
Organ-on-chip technology enters next stage as experts test hepatitis B virus
Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs. (2018-02-14)
Who found some new mechanisms of HBV virulence?
Despite the existence of safe and efficient vaccines, hepatitis B virus is one of the most deadly viruses in the world, killing about 1.2 million people every year. (2008-02-22)
New test allows for one-step diagnosis of HCV infection
The current standard in diagnosing Hepatitis C virus (HCV) infection requires two sequential steps that make it suboptimal, costly, inconvenient, time consuming, and globally not widely available or affordable. (2016-06-07)
Could the biological clock be a key ally in the fight against inflammatory disease?
What if the symptoms and seriousness of certain inflammatory diseases were linked to time of day? (2018-01-26)
'Increased risk' donor organs a tough sell to transplant patients
The opioid epidemic has created a tragic surge in donor organs. (2017-10-05)
First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection
Studies conducted in Italy and Germany confirm the effectiveness and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection, with viral suppression rates similar to those observed in clinical trials. (2018-04-12)
Punjab, India: Mass treatment of a population with chronic hepatitis C infection produces high rates of cure
A program of decentralized public healthcare achieves high rates of cure regardless of genotype or the presence of cirrhosis: the Punjab Model. (2018-04-12)
Hepatitis C care falling short for young opioid users in R.I.
New research finds that while many Rhode Island young adults who use opioids get screened for hepatitis C, they aren't always connected to care for an infection if one is detected. (2017-10-25)
Cancer stem cells, allies of the tumor and enemies of the patient
Research results point to a therapeutic value for the protein (Ahr) because controlling it might repress the pluripotency of the cancer stem cell and reduce the malignity of the tumour. (2018-03-05)
Cellular mechanism for severe viral hepatitis identified
KAIST medical scientists identified a cellular mechanism causing inflammatory changes in regulatory T cells that can lead to severe viral hepatitis. (2018-01-18)
How the hepatitis B virus establishes persistent infection
New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao Guo of the Indiana University School of Medicine, Bin Wang and Jiming Zhang of Fudan University, and colleagues. (2019-04-18)
National Academies target opioid abuse and infectious disease consequences
The National Academies of Sciences, Engineering, and Medicine today released proceedings of a March 12 workshop exploring the rise in infectious diseases accompanying opioid abuse, and possible strategies for reducing both epidemics. (2018-07-13)
Dibenzoazepine defender: Drug found to be effective against resistant hepatitis C
Osaka University researchers identify class of chemicals that can combat resistant strains of the hepatitis C virus, as well as parasites that cause malaria and toxoplasmosis (2017-12-06)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...